These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19288578)

  • 1. Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder.
    Miller JM; Kinnally EL; Ogden RT; Oquendo MA; Mann JJ; Parsey RV
    Synapse; 2009 Jul; 63(7):565-73. PubMed ID: 19288578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain.
    Parsey RV; Hastings RS; Oquendo MA; Hu X; Goldman D; Huang YY; Simpson N; Arcement J; Huang Y; Ogden RT; Van Heertum RL; Arango V; Mann JJ
    Am J Psychiatry; 2006 Jan; 163(1):48-51. PubMed ID: 16390888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower serotonin transporter binding potential in the human brain during major depressive episodes.
    Parsey RV; Hastings RS; Oquendo MA; Huang YY; Simpson N; Arcement J; Huang Y; Ogden RT; Van Heertum RL; Arango V; Mann JJ
    Am J Psychiatry; 2006 Jan; 163(1):52-8. PubMed ID: 16390889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.
    Schneck N; Miller JM; Delorenzo C; Kikuchi T; Sublette ME; Oquendo MA; Mann JJ; Parsey RV
    J Affect Disord; 2016 Jan; 190():494-498. PubMed ID: 26561939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.
    Miller JM; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
    J Psychiatr Res; 2008 Oct; 42(14):1137-44. PubMed ID: 18331740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography.
    Oquendo MA; Hastings RS; Huang YY; Simpson N; Ogden RT; Hu XZ; Goldman D; Arango V; Van Heertum RL; Mann JJ; Parsey RV
    Arch Gen Psychiatry; 2007 Feb; 64(2):201-8. PubMed ID: 17283287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.
    Miller JM; Everett BA; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
    Synapse; 2016 Jan; 70(1):24-32. PubMed ID: 26426356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking moderates association of 5-HTTLPR and in vivo availability of serotonin transporters.
    Smolka MN; Reimold M; Kobiella A; Reischl G; Rietschel M; Heinz A
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):171-178. PubMed ID: 30587400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A positron emission tomography study of the serotonergic system in relation to anxiety in depression.
    Iscan Z; Rakesh G; Rossano S; Yang J; Zhang M; Miller J; Sullivan GM; Sharma P; McClure M; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):1011-1021. PubMed ID: 28811068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder.
    Miller JM; Hesselgrave N; Ogden RT; Sullivan GM; Oquendo MA; Mann JJ; Parsey RV
    Biol Psychiatry; 2013 Aug; 74(4):287-95. PubMed ID: 23453288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior.
    Bartlett EA; Zanderigo F; Stanley B; Choo TH; Galfalvy HC; Pantazatos SP; Sublette ME; Miller JM; Oquendo MA; Mann JJ
    Eur Neuropsychopharmacol; 2023 May; 70():1-13. PubMed ID: 36780841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.
    Aguilera M; Arias B; Wichers M; Barrantes-Vidal N; Moya J; Villa H; van Os J; Ibáñez MI; Ruipérez MA; Ortet G; Fañanás L
    Psychol Med; 2009 Sep; 39(9):1425-32. PubMed ID: 19215635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.
    Murthy NV; Selvaraj S; Cowen PJ; Bhagwagar Z; Riedel WJ; Peers P; Kennedy JL; Sahakian BJ; Laruelle MA; Rabiner EA; Grasby PM
    Neuroimage; 2010 Aug; 52(1):50-4. PubMed ID: 20406689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.
    Meyer JH
    J Psychiatry Neurosci; 2007 Mar; 32(2):86-102. PubMed ID: 17353938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.
    Miller JM; Brennan KG; Ogden TR; Oquendo MA; Sullivan GM; Mann JJ; Parsey RV
    Neuropsychopharmacology; 2009 Sep; 34(10):2275-84. PubMed ID: 19458612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.
    Hammoud DA; Endres CJ; Hammond E; Uzuner O; Brown A; Nath A; Kaplin AI; Pomper MG
    Neuroimage; 2010 Feb; 49(3):2588-95. PubMed ID: 19853044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.